Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A.
about
Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical DataMacrophage diversity enhances tumor progression and metastasisControl of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysisCD163+CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinomaInflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasisDiallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion.Inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo.Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanomaDifferential macrophage programming in the tumor microenvironment.Clinical utilization of chemokines to combat cancer: the double-edged sword.Myeloid cell trafficking and tumor angiogenesisMelanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature.Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.Inflammation and cancer: role of nuclear factor-kappaB activation.Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment.Mononuclear phagocytes in head and neck squamous cell carcinoma.SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway.Small-molecule protein kinase inhibitors and their effects on the immune system: implications for cancer treatment.Primary Tr1 cells from metastatic melanoma eliminate tumor-promoting macrophages through granzyme B- and perforin-dependent mechanisms.Role of tumor-associated macrophages in human malignancies: friend or foe?One microenvironment does not fit all: heterogeneity beyond cancer cells.Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration.Innate immunity in cutaneous melanoma.Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.Inflammation and tumor microenvironment in lymph node metastasis.Endogenous PGE(2) induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma.The shedded ectodomain of Lyve-1 expressed on M2-like tumor-associated macrophages inhibits melanoma cell proliferation.T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissueCancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
P2860
Q26781098-5C2286CA-B7E0-4A10-ADAC-0DE3FBC3486EQ29615847-682D22AC-D64F-42DA-B2BE-6CB4B5F2A328Q29994573-9E193AD8-40EC-4D00-B35B-18692E08BDBFQ33265638-7E14F1A5-8132-4B81-8224-827FC4629426Q33687268-86DE83BC-2C90-4DE9-969C-8C86E0A32ED8Q33967503-A9F6DB23-7538-4930-AF2D-C818561F1A28Q34056943-18A234C2-4A75-41B8-B136-2C5DDA7FE54AQ34230447-7212F037-003D-4254-ABD8-4B31535EE96FQ34799434-FFAA42A6-4F18-4908-B170-997012C3168AQ35234354-CF2800FE-2460-4C16-976F-19FB3272F457Q35803027-6938962E-334B-40A5-9BD4-0DC15925D259Q36488894-F24B6C23-5E71-4B71-A62E-F7D4A7F9CE5CQ36627580-20DEE3CD-909A-41DF-8CAF-845EBED73243Q36738000-8E92F172-6A0A-4A60-A567-302DE5CC4771Q37088617-D4ECDE88-0015-4FA9-AB48-3006525CCD86Q37092305-CA1CD868-123B-411F-937F-8A484B8B9F6CQ37412903-9F5E70E8-97DE-4113-84DD-11B0D3EF2501Q37646333-7C60F944-24AB-4395-BF04-D865ACA950BDQ37652928-419BCEAB-7573-431D-A888-A7F3F8FA9FE0Q37842326-8B3EACB1-B4E1-441A-86AC-6345C9D810BDQ38853772-1B640B67-A924-45D8-9997-9C3CF45B979AQ38904869-774EB6C9-77FC-4385-9CE0-8DE4B1A1B15BQ39011826-5B01AC42-2D3D-4447-8A65-28F1BC54DE3CQ39063857-57EBA44C-9DE2-4E9E-A35F-32184A92FF78Q39067256-09FD41BB-C597-417A-AD92-F2346BF2D3E7Q39198190-ECAE3B2A-7C07-4997-880C-81875BA2D53BQ39799151-AC0164A8-7237-4671-800B-39B837EB69A3Q43247091-005EBB39-C630-48C1-86D5-640E900C80CBQ47270219-BE1868B3-C6D5-474E-BC19-413F39B1C50FQ52593234-AFEBF6F3-D34C-4458-A248-A7F7E837168DQ58260579-02660DE3-F55B-49E0-8B08-923969D4ED1CQ58781616-5E26E398-D36D-4832-B286-A4800031A213
P2860
Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Tumour-associated macrophage i ...... r endothelial growth factor-A.
@en
type
label
Tumour-associated macrophage i ...... r endothelial growth factor-A.
@en
prefLabel
Tumour-associated macrophage i ...... r endothelial growth factor-A.
@en
P2093
P921
P1433
P1476
Tumour-associated macrophage i ...... r endothelial growth factor-A.
@en
P2093
Michelle L Varney
Rakesh K Singh
Sonny L Johansson
P304
P356
10.1097/00008390-200510000-00010
P407
P577
2005-10-01T00:00:00Z